First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
Clinical trial NCT07527923 · RECRUITING
Trial details
- NCT number
- NCT07527923
- Sponsor
- Regeneron Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-22
- Primary completion
- 2028-06-23
- Enrollment
- 144
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.